| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |